Fasting venous blood samples were collected after an overnight fast (≥ 8 h) both at baseline and during follow-up. Glycated haemoglobin and FPG were measured on whole never-frozen blood immediately after blood collection. Glycated haemoglobin was measured using boronate affinity chromatography assay (Trinity Biotech, County Wicklow, Ireland) and FPG was measured using enzymatic colourimetric assay (F. Hoffmann-La Roche, Basel, Switzerland). The other collected tubes of blood were centrifuged at 4000 g for5.5 min at 4°C, plasma separated, aliquoted, and stored at −80°C for future analyses.Amylin, C-peptide, glucagon, glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1), insulin, pancreatic polypeptide, and peptide YY were measured in plasma samples using the MILLIPLEX® MAP human metabolic hormone magnetic bead panel. Protease (Merck KGaA) and DPP-IV inhibitors (Merck KGaA) were added to the samples. All assays were conducted as per the user’s manual. Results were quantified using the BelysaTM immunoassay curve fitting software (Merck KGaA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.